Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 4/20 | 0.39 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.38 |
| ▸ | KDM6B | O15054 | 1/20 | 0.38 |
| ▸ | KDM5C | P41229 | 1/20 | 0.38 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.38 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.38 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.38 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.38 |
| ▸ | PAM | P19021 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.33 |
| ▸ | DGKA | P23743 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2177185 | 0.87 | TSHR (0.56) | TSHRSLC22A6LMNAEGLN1ALKBH5 | |
| SCHEMBL1237232 | 0.87 | LMNA (0.50) | TSHRSLC22A6LMNAEGLN1KDM6B | |
| SCHEMBL2209527 | 0.87 | TSHR (0.54) | TSHRSLC22A6LMNAEGLN1KDM6B | |
| SCHEMBL29212612 | 0.84 | TSHR (0.52) | TSHRSLC22A6LMNAEGLN1KDM6B | |
| Ammonia Solution, Strong SCHEMBL28947727 | 0.82 | TSHR (0.56) | TSHRSLC22A6LMNAEGLN1KDM6B | |
| SCHEMBL10757164 | 0.82 | LMNA (0.55) | TSHRSLC22A6LMNAPAMCAMK2A | |
| SCHEMBL2480634 | 0.82 | TSHR (0.56) | TSHRSLC22A6LMNAEGLN1KDM6B | |
| Adipic Acid SCHEMBL27504325 | 0.82 | TSHR (0.56) | TSHRSLC22A6LMNAEGLN1KDM6B | |
| SCHEMBL429060 | 0.82 | LMNA (0.53) | TSHRSLC22A6LMNAEGLN1KDM6B | |
| SCHEMBL1602470 | 0.82 | SLC22A6 (0.61) | TSHRSLC22A6LMNAEGLN1KDM6B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10689673-B2 | Bioconversion process for producing nylon-7, nylon-7,7 and polyesters | INVISTA NORTH AMERICA S.A.R.L. (US) | 2020-06-23 | — | — | US | disclosed |
| US-10577634-B2 | Bioconversion process for producing nylon-7, nylon-7,7 and polyesters | INVISTA NORTH AMERICA S.A.R.L. (US) | 2020-03-03 | — | — | US | disclosed |
| US-20170298396-A1 | BIOCONVERSION PROCESS FOR PRODUCING NYLON-7, NYLON-7,7 AND POLYESTERS | INV NYLON CHEMICALS AMERICAS, LLC | 2017-10-19 | — | — | US | disclosed |
| US-9650653-B2 | Bioconversion process for producing nylon-7, nylon-7,7 and polyesters | INVISTA NORTH AMERICA S.A.R.L. (US) | 2017-05-16 | — | — | US | disclosed |
| US-20150337275-A1 | BIOCONVERSION PROCESS FOR PRODUCING NYLON-7, NYLON-7,7 AND POLYESTERS | INVISTA TECHNOLOGIES S.A.R.L. (CH) | 2015-11-26 | — | — | US | disclosed |
| US-20150240226-A1 | NUCLEIC ACIDS AND PROTEINS AND METHODS FOR MAKING AND USING THEM | BP CORP NORTH AMERICA INC (US) | 2015-08-27 | — | — | US | disclosed |
| US-8962800-B2 | Nucleic acids and proteins and methods for making and using them | BP CORPORATION NORTH AMERICA INC. (US) | 2015-02-24 | — | — | US | disclosed |
| US-20140242655-A1 | Bioconversion Process for Producing Nylon-7, Nylon-7, 7 and Polyesters | INVISTA TECHNOLOGIES S.A R.L. (CH) | 2014-08-28 | — | — | US | disclosed |
| US-20120266329-A1 | Nucleic Acids and Proteins and Methods for Making and Using Them | BP CORPORATION NORTH AMERICA INC. (US) | 2012-10-18 | — | — | US | disclosed |
| US-8119385-B2 | Nucleic acids and proteins and methods for making and using them | BP CORPORATION NORTH AMERICA INC. (US) | 2012-02-21 | — | — | US | disclosed |
| US-20110296543-A1 | NUCLEIC ACIDS AND PROTEINS AND METHODS FOR MAKING AND USING THEM | THE UNIVERSITY OF CALIFORNIA (US) | 2011-12-01 | — | — | US | disclosed |
| US-20100011456-A1 | Nucleic Acids and Proteins and Methods for Making and Using Them | VERENIUM CORPORATION (US) | 2010-01-14 | — | — | US | disclosed |
| EP-1765418-A4 | METHOD FOR ENHANCING PRODUCTION OF ISOPRENOID COMPOUNDS | UNIV CALIFORNIA (US) | 2008-07-02 | — | — | EP | disclosed |
| EP-1765418-A2 | METHOD FOR ENHANCING PRODUCTION OF ISOPRENOID COMPOUNDS | The Regents of the University of California (US) | 2007-03-28 | — | — | EP | disclosed |
| WO-2006085899-A2 | METHOD FOR ENHANCING PRODUCTION OF ISOPRENOID COMPOUNDS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2006-08-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150240226-A1 | NUCLEIC ACIDS AND PROTEINS AND METHODS FOR MAKING AND USING THEM | POLN, POLM, POLI | TSHR 2116/4885SLC22A6 3956/4885LMNA 389/4885 |
| US-20120266329-A1 | Nucleic Acids and Proteins and Methods for Making and Using Them | POLN, POLM, POLI | TSHR 2116/4885SLC22A6 3956/4885LMNA 389/4885 |
| US-20100011456-A1 | Nucleic Acids and Proteins and Methods for Making and Using Them | POLN, POLM, POLI | TSHR 2116/4885SLC22A6 3956/4885LMNA 389/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.